IONS
Ionis Pharmaceuticals Inc
45.80$
+1.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +32.5% | +22.2% | +48.3% | +16.6% | +87.3% | -35.1% | +11.2% | -27.5% | +34.1% | -10.5% | +33.9% | |
| – | +33.3% | +6.8% | +8.8% | -99.5% | +119.8% | +200.0% | -9.7% | +30.2% | -35.3% | +22.8% | +42.7% | |
| – | – | – | +22,255.6% | +16.3% | +87.2% | -35.9% | +11.5% | -28.3% | +35.8% | -10.9% | +33.7% | |
| – | +33.3% | +6.8% | +8.8% | +10.7% | +12.4% | +14.8% | +20.2% | +29.5% | +8.0% | +0.2% | +1.6% | |
| – | +84.6% | +30.8% | +123.2% | +125.5% | +17.3% | +23.3% | -51.7% | -12.1% | +54.8% | +15.0% | +47.3% | |
| – | +84.6% | +957.0% | +23.0% | +36.4% | +14.2% | +18.1% | -6.7% | +18.5% | +15.1% | +3.2% | +12.1% | |
| – | – | – | – | -297.7% | – | -147.0% | – | – | – | – | – | |
| – | +65.4% | +5.6% | +15.4% | +0.1% | +9.4% | -8.2% | -79.2% | -13.1% | +902.9% | +11.0% | +0.1% | |
| – | – | – | – | – | – | -149.0% | – | – | – | – | – | |
| – | – | +688.7% | -303.8% | – | – | +620.5% | -100.2% | – | +175.4% | -119.1% | – | |
| – | – | – | – | +79,015.9% | +7.4% | -265.6% | – | – | – | – | – | |
| – | – | – | – | -151.8% | – | -140.5% | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.